Indication and Approval

Aggrenox®/Asasantin® is a antithrombotic agent intended for oral administration. Each hard gelatin capsule contains 200 mg dipyridamole in an extended or modified release form and 25 mg ASA as an immediate release sugar-coated tablet. In addition, each capsule contains the following inactive ingredients: acacia, aluminum stearate, colloidal silicon dioxide, corn starch, dimethicone, hydroxypropyl methylcellulose, hydroxypropyl methylcellulose phthalate, lactose monohydrate, methacrylic acid copolymer, microcrystalline cellulose, povidone, stearic acid, sucrose, talc, tartaric acid, titanium dioxide, and triacetin.
Each capsule shell contains gelatin, red iron oxide and yellow iron oxide, titanium dioxide, and water.